BCAB Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 11.50%

Insider Buying (Last 12 Months): $157,320.00

Insider Selling (Last 12 Months): $0.00

BioAtla Insider Trading History Chart

BioAtla Share Price & Price History

^$1.27

▲ +0.085 (7.20%)

As of 12/19/2024 10:46 AM ET

Days: 30 | 90 | 365

Is Starlink Set For The Largest IPO In History?

From Paradigm Press | Ad

He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again with Tesla… which is up more than 19,500% since 2010. For perspective, that turns $100 invested into almost $20,000!

Click here now for the urgent details.

BioAtla Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
12/26/2023	Sylvia Mcbrinn	Director	Buy	4,000	$2.33	$9,320.00	15,125
12/20/2023	Jay M. Short	CEO	Buy	50,000	$2.14	$107,000.00	1,439,283
12/19/2023	Lawrence Steinman	Director	Buy	20,000	$2.05	$41,000.00	38,459
9/8/2023	Sylvia Mcbrinn	Director	Buy	2,000	$2.54	$5,080.00	11,125
3/29/2023	Jay M. Short	CEO	Buy	40,800	$2.47	$100,776.00	1,412,387
3/28/2023	Christian Vasquez	Insider	Buy	20,000	$2.40	$48,000.00	102,709
12/19/2022	Sylvia Mcbrinn	Director	Buy	3,700	$8.33	$30,821.00	9,125
11/22/2022	Sylvia Mcbrinn	Director	Buy	2,000	$8.27	$16,540.00	5,425
9/12/2022	Sylvia Mcbrinn	Director	Buy	2,000	$8.85	$17,700.00	2,000
8/12/2022	Jay M. Short	CEO	Buy	26,350	$7.84	$206,584.00	1,396,556
6/21/2022	Jay M. Short	CEO	Buy	29,082	$2.79	$81,138.78	1,335,674
6/9/2022	Christian Vasquez	Insider	Buy	10,000	$2.97	$29,700.00	74,525
6/7/2022	Christian Vasquez	Insider	Buy	14,152	$3.04	$43,022.08	38,677

Is Starlink Set For The Largest IPO In History?

From Paradigm Press | Ad

Click here now for the urgent details.

SEC Filings (Institutional Ownership Changes) for BioAtla (NASDAQ:BCAB)

77.23% of BioAtla stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

BioAtla Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
11/15/2024	XTX Topco Ltd	154,967	$0.27M	0.0%	+7.2%	0.321%
11/15/2024	Jane Street Group LLC	49,087	$86K	0.0%	-64.1%	0.102%
11/15/2024	Point72 Asia Singapore Pte. Ltd.	36,899	$65K	0.0%	-48.9%	0.076%
11/12/2024	Massachusetts Financial Services Co. MA	569,332	$1M	0.0%	+5.2%	1.178%
11/7/2024	MAI Capital Management	452,092	$0.80M	0.0%	-5.3%	0.935%
11/6/2024	Cornercap Investment Counsel Inc.	29,805	$52K	0.0%	-50.8%	0.062%
11/5/2024	GSA Capital Partners LLP	353,769	$0.62M	0.0%	N/A	0.732%
10/29/2024	Chicago Partners Investment Group LLC	23,217	$44K	0.0%	N/A	0.048%
10/16/2024	Vontobel Holding Ltd.	16,000	$28K	0.0%	N/A	0.033%
9/16/2024	Point72 Asia Singapore Pte. Ltd.	72,193	$99K	0.0%	N/A	0.150%
8/15/2024	Scion Asset Management LLC	633,959	$0.87M	1.7%	N/A	1.318%
8/15/2024	AQR Capital Management LLC	636,136	$0.87M	0.0%	N/A	1.322%
8/15/2024	Point72 Asia Singapore Pte. Ltd.	72,193	$99K	0.0%	N/A	0.150%
8/14/2024	Bank of Montreal Can	404,198	$0.55M	0.0%	+55.1%	0.840%
8/12/2024	XTX Topco Ltd	144,583	$0.20M	0.0%	-12.0%	0.300%
8/9/2024	Renaissance Technologies LLC	625,500	$0.86M	0.0%	-37.2%	1.300%
8/9/2024	Dimensional Fund Advisors LP	333,858	$0.46M	0.0%	+28.3%	0.694%
8/9/2024	Massachusetts Financial Services Co. MA	541,199	$0.74M	0.0%	+2.8%	1.125%
8/8/2024	American Century Companies Inc.	43,391	$59K	0.0%	+36.1%	0.090%
8/8/2024	Ground Swell Capital LLC	24,063	$33K	0.0%	N/A	0.050%
8/6/2024	Acadian Asset Management LLC	75,031	$0.10M	0.0%	-51.7%	0.156%
8/1/2024	Rhumbline Advisers	20,151	$28K	0.0%	-67.9%	0.042%
8/1/2024	Valmark Advisers Inc.	25,126	$34K	0.0%	N/A	0.052%
8/1/2024	Rinkey Investments	25,310	$35K	0.0%	N/A	0.053%
5/20/2024	Virtu Financial LLC	30,012	$0.10M	0.0%	N/A	0.062%
5/17/2024	Tidal Investments LLC	145,174	$0.50M	0.0%	-5.9%	0.302%
5/15/2024	Price T Rowe Associates Inc. MD	12,791	$45K	0.0%	N/A	0.027%
5/10/2024	Acadian Asset Management LLC	155,188	$0.53M	0.0%	+57.6%	0.323%
5/10/2024	Vanguard Group Inc.	2,099,037	$7.22M	0.0%	+0.8%	4.364%
5/7/2024	SG Americas Securities LLC	13,069	$45K	0.0%	-42.3%	0.027%
5/2/2024	Chase Investment Counsel Corp	76,742	$0.26M	0.1%	N/A	0.160%
3/12/2024	PVG Asset Management Corp	65,335	$0.16M	0.8%	N/A	0.136%
2/26/2024	Perceptive Advisors LLC	73,000	$0.18M	0.0%	N/A	0.152%
2/14/2024	Pale Fire Capital SE	48,383	$0.12M	0.0%	+204.6%	0.101%
2/8/2024	Panagora Asset Management Inc.	111,366	$0.27M	0.0%	+110.0%	0.232%
2/7/2024	Formidable Asset Management LLC	154,246	$0.38M	0.1%	-5.3%	0.322%
2/2/2024	Simplex Trading LLC	11,926	$29K	0.0%	-71.3%	0.025%
2/1/2024	SC&H Financial Advisors Inc.	65,519	$0.16M	0.0%	-7.9%	0.137%
1/30/2024	Vontobel Holding Ltd.	706,062	$1.74M	0.0%	-1.3%	1.473%
1/1/2024	Vanguard Group Inc.	2,102,316	$3.57M	0.0%	+0.2%	4.385%
11/15/2023	Sectoral Asset Management Inc.	706,062	$1.20M	0.2%	+26.9%	1.477%
11/15/2023	Adage Capital Partners GP L.L.C.	1,796,148	$3.05M	0.0%	-5.2%	3.757%
11/15/2023	Affinity Asset Advisors LLC	180,000	$0.31M	0.1%	-44.6%	0.377%
11/9/2023	Formidable Asset Management LLC	162,794	$0.28M	0.1%	+79.0%	0.341%
11/9/2023	Deutsche Bank AG	279,122	$0.48M	0.0%	-59.7%	0.584%
11/8/2023	Vivo Capital LLC	534,181	$0.91M	0.1%	-16.2%	1.118%
11/8/2023	Massachusetts Financial Services Co. MA	528,667	$0.90M	0.0%	-30.1%	1.106%
10/31/2023	Panagora Asset Management Inc.	53,030	$90K	0.0%	N/A	0.111%
10/30/2023	SC&H Financial Advisors Inc.	71,125	$0.12M	0.0%	+232.4%	0.149%
10/13/2023	SG Americas Securities LLC	21,963	$37K	0.0%	N/A	0.046%
10/11/2023	Vontobel Holding Ltd.	715,195	$1.22M	0.0%	+26.4%	1.496%
9/21/2023	Barclays PLC	8,827	$27K	0.0%	N/A	0.018%
8/11/2023	Pale Fire Capital SE	15,883	$48K	0.0%	N/A	0.033%
8/11/2023	MYDA Advisors LLC	60,000	$0.18M	0.1%	+9.1%	0.126%
8/11/2023	Sectoral Asset Management Inc.	556,518	$1.67M	0.3%	+2.5%	1.167%
8/8/2023	Wasatch Advisors LP	1,500,934	$4.50M	0.0%	+18.4%	3.149%
8/4/2023	American International Group Inc.	21,290	$64K	0.0%	N/A	0.045%
8/2/2023	Bank of Montreal Can	16,078	$62K	0.0%	N/A	0.034%
7/24/2023	Vontobel Holding Ltd.	565,651	$1.70M	0.0%	+2.4%	1.187%
7/13/2023	Transcend Capital Advisors LLC	49,000	$0.15M	0.0%	N/A	0.103%
6/1/2023	Prelude Capital Management LLC	12,846	$34K	0.0%	-20.6%	0.027%
5/15/2023	Affinity Asset Advisors LLC	325,000	$0.87M	0.3%	+116.7%	0.683%
5/15/2023	MYDA Advisors LLC	55,000	$0.15M	0.1%	N/A	0.116%
5/12/2023	Sectoral Asset Management Inc.	543,009	$1.46M	0.3%	+292.6%	1.141%
5/11/2023	Cornercap Investment Counsel Inc.	61,534	$0.17M	0.0%	+89.0%	0.129%
5/10/2023	Connor Clark & Lunn Investment Management Ltd.	48,614	$0.13M	0.0%	N/A	0.102%
5/9/2023	Formidable Asset Management LLC	90,935	$0.24M	0.1%	+162.8%	0.191%
5/3/2023	Jump Financial LLC	46,800	$0.13M	0.0%	N/A	0.098%
5/1/2023	Virtu Financial LLC	10,302	$28K	0.0%	N/A	0.022%
4/12/2023	Vontobel Holding Ltd.	552,142	$1.48M	0.0%	+274.5%	1.160%
2/15/2023	Tang Capital Management LLC	3,124,076	$25.77M	3.7%	+58.8%	8.307%
2/15/2023	Endurant Capital Management LP	136,382	$1.13M	0.5%	N/A	0.363%
2/15/2023	Avidity Partners Management LP	1,260,000	$10.40M	0.2%	N/A	3.350%
2/14/2023	683 Capital Management LLC	18,593	$0.15M	0.0%	N/A	0.049%
2/14/2023	EcoR1 Capital LLC	1,124,439	$9.28M	0.3%	N/A	2.990%
2/13/2023	Vivo Capital LLC	637,181	$5.26M	0.6%	N/A	1.694%
2/10/2023	Opaleye Management Inc.	261,800	$2.16M	0.8%	N/A	0.696%
2/10/2023	Sectoral Asset Management Inc.	138,294	$1.14M	0.2%	N/A	0.368%
2/9/2023	Citigroup Inc.	40,876	$0.34M	0.0%	+1,611.7%	0.109%
2/7/2023	Fox Run Management L.L.C.	25,490	$0.21M	0.1%	N/A	0.068%
2/7/2023	Commonwealth Equity Services LLC	20,000	$0.17M	0.0%	N/A	0.053%
2/7/2023	Formidable Asset Management LLC	34,607	$0.29M	0.1%	-16.4%	0.092%
2/7/2023	Bleakley Financial Group LLC	10,407	$86K	0.0%	N/A	0.028%
11/15/2022	Tang Capital Management LLC	1,967,051	$15.15M	1.9%	-41.7%	5.231%
11/15/2022	Eventide Asset Management LLC	795,000	$6.12M	0.1%	N/A	2.114%
11/15/2022	Formidable Asset Management LLC	41,420	$0.32M	0.1%	-42.5%	0.110%
11/14/2022	Cormorant Asset Management LP	2,181,115	$16.80M	1.2%	+7.0%	5.800%
11/14/2022	Point72 Asset Management L.P.	764,700	$5.89M	0.0%	N/A	2.033%
11/14/2022	PDT Partners LLC	24,496	$0.19M	0.0%	-76.0%	0.065%
11/14/2022	Renaissance Technologies LLC	565,600	$4.36M	0.0%	-27.5%	1.504%
11/14/2022	Altium Capital Management LP	553,000	$4.26M	1.6%	N/A	1.470%
11/14/2022	Healthcare of Ontario Pension Plan Trust Fund	860,200	$6.62M	0.0%	+101.2%	2.287%
11/14/2022	UBS Oconnor LLC	112,000	$0.86M	0.0%	N/A	0.298%
11/9/2022	Massachusetts Financial Services Co. MA	531,787	$4.10M	0.0%	+7.3%	1.421%
11/2/2022	DekaBank Deutsche Girozentrale	12,500	$95K	0.0%	N/A	0.033%
10/28/2022	Silverarc Capital Management LLC	200,422	$1.54M	0.5%	N/A	0.536%
10/25/2022	Denali Advisors LLC	7,300	$56K	0.0%	N/A	0.020%
10/24/2022	Twin Lakes Capital Management LLC	9,000	$69K	0.1%	N/A	0.024%
8/16/2022	Formidable Asset Management LLC	72,087	$0.21M	0.0%	N/A	0.193%
8/15/2022	Laurion Capital Management LP	292,600	$0.83M	0.0%	N/A	0.782%

Data available starting January 2016

BioAtla, Inc., a clinical-stage biopharmaceutical company, develops specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. The company's lead clinical stage product candidates include mecbotamab vedotin (BA3011), a conditionally active biologic (CAB) antibody-drug conjugate (ADC), which is in Phase II clinical trial for treating undifferentiated pleomorphic sarcoma and non-small cell lung cancer (NSCLC); and ozuriftabmab vedotin (BA3021), a CAB ADC that is in Phase II clinical trial for the treatment of melanoma and squamous cell cancer of the head and neck. It is also developing Evalstotug (BA3071), a CAB anti-cytotoxic T-lymphocyte-associated antigen 4 antibody, which is in Phase II clinical trial for treating melanoma, carcinomas, and NSCLC; and BA3182, a bispecific candidate that is in Phase 1 study for the treatment of adenocarcinomas, as well as BA3361, which is in preclinical studies for treating multiple tumor types. The company was founded in 2007 and is headquartered in San Diego, California.

Today's Range

Now: $1.27

$1.20

$1.27

50 Day Range

MA: $1.78

$1.18

$2.37

52 Week Range

Now: $1.27

$1.14

$4.02

Volume

159,324 shs

Average Volume

837,667 shs

Market Capitalization

$61.16 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.96

Who are the company insiders with the largest holdings of BioAtla?: BioAtla's top insider shareholders include:
Jay M Phd Short (CEO)
Christian Vasquez (Insider)
Lawrence Steinman (Director)
Sylvia Mcbrinn (Director)
Learn More about top insider investors at BioAtla.
Who are the major institutional investors of BioAtla?: BioAtla's top institutional investors include:
Massachusetts Financial Services Co. MA — 1.18%
MAI Capital Management — 0.94%
GSA Capital Partners LLP — 0.73%
XTX Topco Ltd — 0.32%
Jane Street Group LLC — 0.10%
Point72 Asia Singapore Pte. Ltd. — 0.08%
Learn More about top institutional investors of BioAtla stock.
Which major investors are selling BioAtla stock?: In the previous quarter, BCAB stock was sold by these institutional investors:
Jane Street Group LLC
Point72 Asia Singapore Pte. Ltd.
Cornercap Investment Counsel Inc.
MAI Capital Management
Which major investors are buying BioAtla stock?: During the last quarter, BCAB stock was acquired by institutional investors including:
GSA Capital Partners LLP
Massachusetts Financial Services Co. MA
Chicago Partners Investment Group LLC
Vontobel Holding Ltd.
XTX Topco Ltd
During the last year, these company insiders have bought BioAtla stock:
Jay M Phd Short (CEO)
Christian Vasquez (Insider)
Lawrence Steinman (Director)
Sylvia Mcbrinn (Director)
Learn More investors buying BioAtla stock.

From Behind the Markets | Ad

My research indicates there is only one investment that can meet AI's unprecedented demand for energy.

Click to get the name and ticker symbol